Publications by authors named "Nathaniel Rosko"

Claim this Profile
I
Incidence and Management of Carfilzomib-induced Cardiovascular Toxicity; A Systematic Review and Meta-analysis.
Azka Latif, Vikas Kapoor, Noman Lateef, Muhammad J Ahsan, Rana M Usman, Nathaniel Rosko

Cardiovasc Hematol Disord Drug Targets· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma.
Diana Basali, Rajshekhar Chakraborty, Lisa Rybicki, Nathaniel Rosko, Janice Reed

Br J Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma.
Rajshekhar Chakraborty, Lisa Rybicki, Megan O Nakashima, Robert M Dean, Beth M Faiman, Nathaniel Rosko

Br J Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of relapsed multiple myeloma: Evidence-based recommendations.
Ceren Durer, Seren Durer, Sarah Lee, Rajshekhar Chakraborty, Mustafa Nadeem Malik, Nathaniel Rosko

Blood Rev· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development.
Ahmad Iftikhar, Hamza Hassan, Nimra Iftikhar, Adeela Mushtaq, Atif Sohail, Nathaniel Rosko

Antibodies (Basel)· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis